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Abstract
Dengue virus (DENV) is an enveloped RNA virus that causes the most common arthropod-borne infection worldwide. The
mechanism by which DENV infects the host cell remains unclear. In this work, we used live-cell imaging and single-virus
tracking to investigate the cell entry, endocytic trafficking, and fusion behavior of DENV. Simultaneous tracking of DENV
particles and various endocytic markers revealed that DENV enters cells exclusively via clathrin-mediated endocytosis. The
virus particles move along the cell surface in a diffusive manner before being captured by a pre-existing clathrin-coated pit.
Upon clathrin-mediated entry, DENV particles are transported to Rab5-positive endosomes, which subsequently mature into
late endosomes through acquisition of Rab7 and loss of Rab5. Fusion of the viral membrane with the endosomal membrane
was primarily detected in late endosomal compartments.
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Introduction
Dengue virus (DENV) is a mosquito-transmitted, enveloped
RNA virus that belongs to the family Flaviviridae. This family also
includes West-Nile virus (WNV) and tick-borne encephalitis virus
(TBEV). DENV causes the most common arthropod-borne
infection worldwide with 50–100 million cases annually [1–3].
Despite its threat to human health, there are presently neither
vaccines nor antiviral drugs to prevent or treat dengue infection.
The development of novel therapies requires insight into the viral
life cycle. A potential target for intervention strategies is the
infectious cell entry pathway.
The infectious entry of DENV is mediated by the viral envelope
glycoprotein E, which is organized in 90 homodimers on the
surface of the virion [4,5]. The E glycoprotein is involved in
interaction with cellular receptors as well as the subsequent
membrane fusion process [6–8]. In vitro studies with TBEV
indicate that membrane fusion is triggered upon exposure of the
virus to low pH [8]. At low pH, the E proteins undergo a dramatic
re-organization which leads to the formation of E trimers [9]. The
crystal structure of the E protein has been solved in its dimeric pre-
fusion, and trimeric post-fusion configurations [10,11]. Although
much is known about the molecular mechanisms involved in the
membrane fusion process, many critical questions regarding the
cell entry pathway of flaviviruses remain unanswered.
The cell entry mechanism of DENV remains controversial. Early
electron microscopy studies provided evidence for direct fusion with
theplasmamembrane[12,13], whereasa recent study indicatesthat
DENV enters cellsvia clathrin-mediated endocytosis [14]. Clathrin-
mediated endocytosis involves internalization of ligands and
receptors through a clathrin-coated pit, which buds into the cell
cytosol and delivers its cargo to early endosomes and subsequently
to late endosomes and lysosomes [15–17]. Other flaviviruses have
also been described to infect their host cell via clathrin-mediated
endocytosis [18–21].Evidenceforflavivirusentryviathispathwayis
based on the use of inhibitors of clathrin-mediated uptake, such as
chlorpromazine and dominant-negative mutants of Eps15
[18,20,22]. Furthermore, addition of acidotropic reagents to cells
has been observed to dramatically reduce viral infectivity and
membrane fusion activity, suggesting that flaviviruses mediate
membrane fusion from within acidic endosomes [23–26]. A recent
study on the entry of WNV particles demonstrates that WNV
colocalizes with the early endosome marker EEA-1 (Early
Endosome Antigen-1), and at later time points with the late
endosome/lysosome marker LAMP-1 (Lysosome-Associated Mem-
brane Protein-1) [27]. Taken together, these studies suggest
clathrin-mediated endocytosis as a viable pathway for flavivirus
entry, but the exact manner in which DENV virus particles enter
cells and traffic through the endocytic network remains unclear, as
does the identity of the organelle in which viral fusion occurs.
PLoS Pathogens | www.plospathogens.org 1 December 2008 | Volume 4 | Issue 12 | e1000244In this study, we dissected the cell entry pathway of DENV by
tracking fluorescently labeled DENV particles in living cells
expressing various fluorescent cellular markers using real-time
multi-color fluorescence microscopy. These experiments demon-
strate that DENV infects its host cell via clathrin-mediated
endocytosis. DENV particles move on the cell surface in a diffusive
manner until they join a pre-existing clathrin-coated pit. Following
clathrin-mediated uptake, the majority of DENV particles enter
early endosomes that progress to late endosomes, where
membrane fusion occurs.
Results
Dengue Virus Enters Cells via Clathrin-Mediated
Endocytosis
In order to visualize single DENV particles in living cells, we
labeled the virus with the lipophilic fluorescent probe DiD. The
concentration of the DiD dye in the viral membrane is sufficiently
high so that its fluorescence is largely quenched, but still allows
single DiD-labeled virions to be detected. Membrane fusion can be
observed as fluorescence dequenching. We have shown previously
that this labeling procedure does not affect the infectious
properties of DENV [26]. The tracking experiments were
performed in African green monkey kidney cells (BS-C-1), which
are highly permissive to DENV infection [26,28]. To test whether
DENV is internalized through clathrin-mediated endocytosis, BS-
C-1 cells stably expressing enhanced yellow fluorescent protein
(eYFP) fused to the light chain of clathrin (LCa-eYFP) were used.
We and others have previously shown that LCa-eYFP highlights
more than 95% of the coated pits and vesicles in living cells and
that this fusion protein does not disturb the functional integrity of
clathrin molecules [29,30]. DiD-labeled DENV was added in situ
to these cells at 37uC and fluorescent images were recorded at 2
frames per second for 25 min. Figure 1A shows the distribution of
LCa-eYFP (green) and DiD-labeled DENV particles (red) in a cell.
The LCa-eYFP signal appeared as discrete structures in cells. A
typical example of a DENV entry event is shown in Figure 1B. In
this example, the virus particle first binds to and moves along the
cell surface. Forty-eight seconds post-binding, the virus particle
associates with a discrete spot containing the LCa-eYFP signal.
Thereafter, the clathrin signal around the virus particle increases,
indicating maturation towards a clathrin-coated vesicle. At
94 seconds, the clathrin signal rapidly disappears, presumably
due to uncoating of the clathrin-coated vesicle. Membrane fusion
eventually occurs at 512 seconds post-infection. Quantitative
analysis of 47 virus trajectories revealed that 98% of the DENV
particles that fused with endosomes entered through LCa-eYFP
positive clathrin-coated pits. On average, the clathrin signal
colocalized with the virus particle for 83 seconds (Figure 1C),
which is consistent with previously observed dynamics of clathrin-
mediated endocytosis [30,31].
To confirm that DENV specifically enters cells via clathrin-
mediated endocytosis,we investigatedtheeffectsofchlorpromazine,
a cationic amphiphilic drug that inhibits the formation of clathrin-
coated pits [32], and of a dominant-negative mutant form of Eps15
(E95/295), a protein required for clathrin-dependent uptake [33],
on DENV infectivity. Viral infectivity was severely impaired in cells
treated with chlorpromazine (Figure 1D) and significantly reduced
in cells expressing dominant-negative Eps15 (Figure 1E). Further-
more, no membrane fusion events were seen in real-time virus
tracking experiments in chlorpromazine-treated cells (results not
shown). Taken together, these results indicate that DENV requires
clathrin-mediated endocytosis for its infectious entry.
Dengue Virions Are Delivered to Pre-Existing Clathrin-
Coated Pits by Diffusion
Tracking individual particles also allowed us to determine how
DENV particles recruit clathrin-coated pits. A detailed character-
ization of the individual trajectories showed that virus particles
associate with clathrin on average at 111 s post-attachment to the
cell surface. Nearly all particles (92%) were observed to move
along the cell surface and join a pre-existing clathrin-coated pit.
The remaining minor fraction either appeared to land directly on
a pre-existing clathrin-coated pit or a clathrin-coated pit was
formed directly at the site of the virus particle. An example of the
surface motion of DENV towards a clathrin-coated pit is depicted
in Figure 2A and Video S1, which is published as supporting
information on the web site.
Subsequently, we investigated whether the surface motion of
DENV is characterized by random diffusion or directed
movement. To this end, we plotted the mean-square displacement
(MSD) of each particle prior to association with a clathrin-coated
pit as a function of time. A linear relationship between MSD and
time would indicate simple diffusion, an upward curvature
designates directed motion, and a downward curvature implies
diffusion within a confined region. Figure 2B gives the MSD plot
for 5 typical virus trajectories. The apparent linear relationship
between the MSD and time indicates that DENV moved on the
cell surface in a diffusive manner. During the tracking experi-
ments, we noticed that the mobility of the virus drops when the
particle overlaps with a clathrin-coated pit. To obtain a
quantitative insight into this behavior, we calculated the diffusion
constants from the MSD plots for each particle prior to or during
colocalization with clathrin and used that as a measure for surface
mobility of the virus. The results show that many DENV particles
that were associated with the cell surface were quite mobile, but
once they were captured by a clathrin-coated pit their mobility was
highly reduced (Figure 2C). Furthermore, treatment of cells with
chlorpromazine revealed that DENV particles remained migrating
along the cell surface throughout the duration of the experiment in
a manner similar to that seen for particles prior to clathrin-
mediated entry in untreated cells (Figure 2C).
Author Summary
Dengue virus (DENV) is the most common arthropod-
borne infection worldwide with 50–100 million cases
annually. Despite its high clinical impact, little is known
about the infectious cell entry pathway of the virus.
Previous studies have shown conflicting evidence about
whether the virus fuses directly with the cell plasma
membrane or enters cells by receptor-mediated endocy-
tosis. In this manuscript, we dissect the cell entry pathway
of DENV by tracking single fluorescently labeled DENV
particles in living cells expressing various fluorescent
cellular markers, using real-time multi-color fluorescence
microscopy. We show that DENV particles are delivered to
pre-existing clathrin-coated pits by diffusion along the cell
surface. Following clathrin-mediated uptake, the majority
of DENV particles are transported to early endosomes,
which mature into late endosomes, where membrane
fusion occurs. This is the first study that describes the cell
entry process of DENV at the single particle level and
therefore provides unique mechanistic and kinetic insights
into the route of entry, endocytic trafficking behavior, and
membrane fusion properties of individual DENV particles
in living cells. This paper opens new avenues in flavivirus
biology and will lead toward a better understanding of the
critical determinants in DENV infection.
Cell Entry Pathway of Dengue Virus
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Following clathrin-mediated internalization, virus particles are
typically trafficked along an endocytic pathway, which comprises a
network of highly dynamic vesicles and endosomes. Endocytic
trafficking is regulated by a large family of small Rab GTPases
[34–38]. Specific Rab GTPases are often enriched in distinct
intracellular vesicles and may be used to identify endocytic vesicles
and endosomes. For example, Rab5 and Rab7 primarily decorate
early and late endosomes, respectively [39–41]. Recent live-cell
imaging studies have also revealed a small fraction of the
endosomes containing both Rab5 and Rab7, which likely indicates
intermediate endosomes that are maturing towards late endosomes
[34,35,37].
To study the itinerary of endosomal compartments visited by
DENV, we tracked single DiD-labeled virus particles in BS-C-1
cells co-expressing Rab5 fused to enhanced cyan fluorescent
protein (Rab5-eCFP) and Rab7 fused to enhanced yellow
fluorescent protein (Rab7-eYFP). We have used this approach
before and observed that low level expression of Rab5-eCFP and
Rab7-eYFP in cells does not adversely affect endocytic trafficking
inside the cell [34]. A typical example of a cell co-transfected with
Rab5-eCFP and Rab7-eYFP early after infection with DiD-
Figure 1. DENV enters cells via clathrin-mediated endocytosis. (A) Fluorescent image of a LCa-eYFP-expressing cell (green) infected with DiD-
labeled DENV particles (red). Scale bar is 10 mm. (B) Selected frames from a single DENV particle (red), indicated with the arrow, entering a cell via
clathrin-mediated endocytosis. The numbers designate seconds post-binding. (C) Histogram of the time that DENV particles colocalized with clathrin-
eYFP. (D) DENV infectivity in BS-C-1 cells in the absence or presence of 15 mM chlorpromazine. Viral infectivity was measured at 24 hours post-
infection by counting the number of E protein–expressing cells using immunofluorescence microscopy. The experiment was performed in triplicate,
and the bars represent the average6SD.
* P,0.01. (E) DENV infection in HeLa cells expressing a dominant-negative Eps15 mutant (E95/295) or its
vector control (D3D2). At 30 hours post-transfection, HeLa cells were infected with DENV for 21 hours and subsequently stained for expression of E-
proteins. Cells were analyzed by flow cytometry, and the results are expressed as the percentage infectivity in transfected cells. The experiment was
performed in triplicate, and the bars represent the average6SD.
* P,0.01.
doi:10.1371/journal.ppat.1000244.g001
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Rab7-positive endosomes can be observed as clear distinct spots
that are localized in the cell periphery as well as in the perinuclear
region of the cell. We analyzed 51 virus trajectories in total and
observed that 86% of the particles first enter Rab5-positive early
endosomes; the other 14% of the virions are directly delivered to
Rab5/Rab7-positive intermediate endosomes. An example of
DENV endocytic trafficking is shown in Figure 3B and Video S2,
which is published as supporting information on the web site. At
42 seconds post-binding, this particular virus particle moves with a
velocity of 0.42 mm/s towards an intermediate endosome, as
shown by the colocalization with Rab5-eCFP and Rab7-eYFP.
Subsequently, the intermediate endosome enclosing the virus
particle matures into a late endosome as detected by the
disappearance of the Rab5 signal. At 342 seconds, the virus
particle resides in a Rab7-positive late endosome and induces
membrane fusion from within this organelle at 508 seconds post-
infection as detected by a five-fold increase in the DiD-intensity.
An example of DENV intracellular trafficking via Rab5-positive
endosomes is shown in Video S3, which is published as supporting
information on the website.
We observed different modes of Rab7 accumulation and Rab5
dissociation during endosome maturation. Rab5-positive early
endosomes carrying DENV particles were found to mature either
through a gradual appearance of Rab7 (55%) or by merging with
an existing Rab7-positive endosome (45%). Typical examples of
these modes of Rab7 accumulation are depicted in Figure 3C, and
Videos S4 and S5. Likewise, the exit of the Rab5 signal also
appears to take place in different modes. About 70% of the
intermediate endosomes complete the maturation process by a
gradual release of Rab5 (Figure 3D, Video S6). In the remaining
cases, the virus particle appeared to be sequestered into a Rab7-
enriched domain of the intermediate endosome, which subse-
quently pinched off and moved away as a late endosomal
compartment (Figure 3D, Video S7).
We have previously identified two distinct populations of Rab5-
positive early endosomes [34]. A group of dynamic early
endosomes are transported on microtubules and rapidly mature
towards late endosomes, while the remaining are relatively static
and mature much more slowly. Influenza virus, low density
lipoproteins, and epidermal growth factors were previously found
to be preferentially targeted to the dynamic, rapidly maturing
population, whereas transferrin is non-selectively delivered to both
populations. DENV was non-selectively delivered to both
endosome populations (data not shown).
Dengue Virus Fuses Primarily from within Rab7-Positive
Late Endosomes
Enveloped viruses escape from the endocytic pathway by a
membrane fusion reaction. In our experimental set-up, membrane
fusion can be detected as a sudden increase of DiD fluorescence
due to the dilution of the DiD-probes from the viral membrane
Figure 2. DENV diffuses along the cell surface and joins a pre-existing clathrin-coated pit. (A) Overlay of a series of time-lapsed images of
a virus particle prior to entering a pre-existing clathrin-coated pit. Each depicted virus image (red) is taken 4 seconds apart, and the positions are
connected in time with white arrows. For clarity, the LCa-eYFP signal (green) was averaged over 10 seconds, starting at the moment when the virus
first overlaps the clathrin-coated pit. Scale bar is 10 mm. (B) MSD-plot for 5 example virus trajectories prior to association with clathrin-coated pits. The
diffusion constants are 0.003 mm
2/s (squares), 0.009 mm
2/s (asterisks), 0.047 mm
2/s (triangles), 0.107 mm
2/s (diamonds), and 0.159 mm
2/s (circles). (C)
Diffusion constants of virus particles prior to entrance into a clathrin-coated pit (light gray bars), during colocalization with clathrin (black bars), and
on cells treated with chlorpromazine (dashed bars).
doi:10.1371/journal.ppat.1000244.g002
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examine the nature of the endosomes from which DENV mediates
membrane fusion. Individual virus trajectories showed that the
majority of the virus particles first joined a Rab5-positive
endosome, which then matured through the Rab5/Rab7-coposi-
tive intermediate stage into a Rab7-positive late endosome, were
membrane fusion was observed. Figure 4A gives a quantitative
kinetic analysis of the endocytic trafficking behavior and
membrane fusion events of all analyzed DENV particles.
Internalization of DENV particles appeared to be relatively quick,
since 50% of the particles localized to early endosomes at
3.5 minutes post-attachment to the cell surface. Thereafter, the
particles started to associate with Rab7-positive endosomes. The
first membrane fusion events were detected at 5 minutes post-
infection, and nearly all fusion events occurred within 17 minutes
post-infection. The average time point of membrane fusion was
12.5 min, which is in agreement with our previous results [26].
The vast majority (80%) of particles induced membrane fusion
from within Rab7-positive late endosomes devoid of any
detectable Rab5 signal, while 15% of the particles fused from
within Rab5/Rab7-copositive intermediate endosomes. Only 5%
of the virus particles fused from within Rab5-positive early
endosomes that lack Rab7 (Figure 4B). Membrane fusion was
initiated at on average 5.5 minutes post-entry of DENV into the
Rab7-positive endosomes (Figure 4C).
Our observation that DENV (serotype 2, strain S1) primarily
fuses from within Rab7-positive late endosomes is somewhat
surprising, since a recent report showed that expression of
dominant-negative Rab7T22N did not affect DENV (serotype 2,
strain New Guinea C) infectivity [22]. To investigate whether this
discrepancy is related to the different virus strains used, we
analyzed the infectious properties of both viruses on HeLa cells
expressing dominant-negative Rab5S34N and Rab7T22N. In
agreement with the above results, viral infectivity of S1 was
severely impaired in cells expressing dominant-negative Rab7,
whereas the infectious properties of NGC were unaffected under
the conditions of the experiments (Figure S1). To investigate the
requirement for Rab7 of S1 infectivity in more detail, we
performed single-particle tracking experiments in cells transiently
expressing the dominant-negative Rab7T22N mutant [42,43].
Figure 4D shows that the number of membrane fusion events was
significantly reduced by a factor of 4 in these cells (T-test:
P,0.001), which indicates that S1 needs to travel to Rab7-positive
endosomes to undergo membrane fusion.
Discussion
Despite the medical importance of DENV, little information is
available about the infectious cell entry pathway of the virus. In
this study, we investigated the cell entry process of single DENV
particles in real-time by simultaneous tracking of fluorescently
labeled DENV particles and endocytic structures in cells. This
approach allowed us to obtain mechanistic and kinetic insights
into the route of internalization and endocytic trafficking behavior
of individual DENV particles in living cells.
Previous electron-microscopy studies suggested that DENV
penetrates both mammalian and insect cells by direct fusion with
the plasma membrane [12,13]. In contrast, this report shows that
DENV enters cells via clathrin-mediated endocytosis and fuses
from within late endosomes. We observed that more than 98% of
the particles that underwent membrane fusion, first associated with
a clathrin-coated structure for a substantial time period.
Furthermore, treatment of cells with chlorpromazine as well as
expression of a dominant-negative Eps15 mutant significantly
Figure 3. DENV particles are transported to early endosomes
that mature into late endosomes. (A) Fluorescent images of a cell
expressing Rab5-eCFP (light blue) and Rab7-eYFP (green) upon
infection with DiD-labeled DENV (red). Scale bar is 10 mm. (B) The
selected frames show the endocytic trafficking behavior of a single DiD-
labeled DENV particle (surrounded by a white circle) in a cell. The
numbers designate seconds post-infection. (C) Snapshots of a virus
trajectory showing the modes of Rab7 accumulation. At all time frames,
the virus particle colocalizes with Rab5, but for clarity the signal is not
depicted. Two modes of Rab7 accumulation were observed: a gradual
recruitment of Rab7 (upper panel) or merging of the endosome with an
existing Rab7-positive endosome (lower panel) was observed. The
numbers indicate the time frame (in seconds) of endosome maturation.
(D) Snapshots of a virus showing the modes of Rab5 exit. At all time
frames, the virus particle colocalizes with Rab7, but for clarity the signal
is not depicted. The exit of Rab5 signal also appears to take place in two
different modes: a gradual release of Rab5 (upper panel) or splitting off
a Rab5-containing endosome (lower panel).
doi:10.1371/journal.ppat.1000244.g003
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the explanation is for the discrepancy, but it might be related to
the methodology that was used to investigate the cell entry process
of the virus. The conclusion that DENV utilizes clathrin-mediated
endocytosis for internalization is in agreement with recent
observations of Acosta and co-workers [14]. During the course
of this study, these investigators published that DENV infectivity
in C6/36 mosquito cells is severely inhibited after treatment of the
cells with a variety of chemical and molecular inhibitors of
clathrin-mediated endocytosis.
Real-time imaging studies showed that macromolecules either
induce de novo formation of clathrin-coated pits or are recruited to
pre-existing clathrin-coated pits [31,44,45]. For example, influen-
za virus particles land on the cell surface and induce de novo
formation of clathrin-coated pits at the site of binding [30]. This
study indicates that DENV particles first diffuse along the cell
surface before they encounter pre-existing clathrin-coated pits.
After the virus associates with the pit, the clathrin signal around
the virus particle increases, which implies maturation of the
clathrin-coated pit and formation of a clathrin-coated vesicle.
Thereafter, the clathrin signal rapidly disappears again, typically
within a time scale of a few seconds. This behavior is similar to
that of reoviruses, which have been shown to stabilize and induce
maturation of pre-existing clathrin-coated pits [31].
Recently, several modes of endosome maturation have been
described. Rink et al. showed that Rab5-positive vesicles, which
have split off from a dynamic early endosomal network,
accumulate Rab7 and subsequently gradually lose Rab5 [35].
Vonderheit et al. found that Rab5-positive endosomes, containing
Semliki Forest Virus (SFV) particles, gradually acquire Rab7 in a
separate domain. The SFV particles are sequestered into this
Rab7 domain, which pinches off as a Rab7-positive late
endosome, leaving a Rab5-positive endosome behind [37]. We
observed both modes of endosome maturation. Most DENV
particles progressed from early to late endosomes by gradual
appearance of Rab7 and a gradual loss of Rab5. In addition, 45%
of Rab5-positive endosomes carrying DENV merged with existing
Rab7-positive endosomes. Occasionally, we observed that DENV
particles sequestered into a distinct Rab7 domain, similar to the
behavior observed from endosomes containing SFV [37].
DENV particles predominantly fused from within Rab7-positive
endosomes. Furthermore, the membrane fusion activity was
significantly impaired in cells expressing dominant-negative forms
of Rab7, which indicates that progression of DENV to Rab7-
positive endosomes is important for its infectious entry. In contrast,
Krishnan et al. have recently demonstrated that the infectivity of
DENV-2 strain NGC was not affected by dominant-negative
Rab7, while ablation of Rab5 severely reduced the number of
infected cells [22]. A direct comparison between both virus strains
revealed that viral infectivity of S1 was severely impaired in cells
expressing dominant-negative Rab7, whereas the infectivity of
NGC was unaffected. These results suggest that both virus strains
Figure 4. DENV fuses primarily from within late endosomes. (A) Individual DENV trajectories were aligned to the time of binding to the cell
surface. Fraction of virus particles that colocalize with Rab5 and Rab7, and that undergo membrane fusion are shown as a function of time. (B)
Quantification of the percentage of membrane fusion events in the different endocytic compartments. (C) Histogram of the time that virus particles
spend in Rab7-positive late endosomes prior to the onset of membrane fusion. (D) The number of DENV membrane fusion events in BS-C-1 cells
transfected with Rab7T22N or with a control plasmid. The experiment was carried out more than 10 times and the bars represent the mean6SD.
**
P,0.001.
doi:10.1371/journal.ppat.1000244.g004
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note that DENV-2 strain NGC induces syncytium formation in a
fusion from without assay at pH 6.4, whereas the pH threshold for
the DENV-2 S1 strain is around pH 5.8 (personal communication,
Dr. P. Young, University of Queensland, Australia). The different
pH-dependent properties of these virus strains may therefore
reflect the distinct requirements for functional endocytic trafficking
in cells. Future experiments should reveal whether the pH
threshold determines in which organelle membrane fusion occurs.
DENV particles reside on average for 5.5 min in Rab7-positive
endosomes prior to the onset of membrane fusion. This result is
surprising considering that TBEV efficiently fuses with liposomes
in a model system in a time scale of seconds after low-pH exposure
[46]. Pre-exposure of TBEV to low pH for 10–20 seconds in the
absence of liposomes completely abolishes the membrane fusion
activity of the virus [46]. Similar results were obtained for WNV
(unpublished results, J. Wilschut and J. M. Smit). Our finding that
DENV fuses several minutes after entering a late endosome might
therefore suggest that, in addition to exposure to the acidic lumen
of the late endosome, other cellular factors are involved in the
activation of the membrane fusion machinery of DENV. Another
possibility is that the accumulation of Rab7 significantly precedes
acidification to the fusion pH.
Taken together, we propose the following model for cell entry of
DENV S1 strain. First, the virus particle binds to a cellular
receptor. Subsequently, DENV diffuses as a virus-receptor
complex or rolls over multiple receptors along the cell surface
towards a clathrin-coated pit. Upon capture by a pre-existing
clathrin-coated pit, the virus particles loses its mobility. Then, the
clathrin-coated pit matures and pinches off into the cell cytoplasm
to deliver the particles to Rab5-positive early endosomes. In
general, the early endosome carrying the virus matures into a late
endosome by gradual accumulation of Rab7, followed by a
gradual loss of Rab5. Finally, the DENV particles localize to
Rab7-positive late endosomes and move through the cytoplasm of
the cell until the onset of membrane fusion allows the genetic
material of the virus to be delivered into the cytoplasm.
Single-particle tracking has substantially enriched our knowl-
edge on viral cell entry mechanisms and has revealed previously
unknown aspects of virus-host interactions [30,47,48]. The
mechanistic and kinetic insights offered by this technique provide
a better understanding of disease pathogenesis and may lead to a
rational design of antiviral drugs and vaccines. This is the first
study that describes the cell entry pathway of DENV at a single-
particle level. The parameters obtained in this study will serve as a
framework for our current study on the fate of individual antibody-
opsonized DENV particles into Fc receptor-bearing to elucidate
the molecular basis of antibody-dependent enhancement of
DENV infection.
Materials and Methods
Cells
Aedes albopictus C6/36 cells were maintained in Minimal Essential
Medium (MEM; Life Technologies, Breda, The Netherlands)
supplemented with 10% fetal bovine serum, 25 mM HEPES, 7.5%
sodium bicarbonate, 200 mM glutamine, 100 mMn o n - e s s e n t i a l
amino acids, penicillin (100 U/ml), and streptomycin (100 mg/ml) at
30uC, 5% CO2. HeLa cells were cultured in a 1:1 mix of DMEM
(LifeTechnologies)and HAM (Life Technologies)supplemented with
10% fetal bovine serum, 25 mM HEPES, penicillin (100 U/ml), and
streptomycin (100 mg/ml) at 37uC, 5% CO2. BS-C-1 cells were
maintained in MEM (Invitrogen, Carlsbad, CA, USA) supplemented
with 10% fetal bovine serum at 37uC, 5% CO2. BS-C-1 cells stably
expressing LCa-YFP were created by use of the RetroMax retroviral
expression system (Imgenex, San Diego, CA, USA) and cultured in
BS-C-1 medium [30]. BS-C-1 cells were grown on glass coverslips
(MatTek, Ashland, MA, USA), and prior to the tracking experiments
washed with serum-free, phenol red-free medium.
DNA Transfection of Cells
The plasmid encoding Rab5-eCFP was a gift from Dr. M. Zerial
(Max Planck Institute, Dresden, Germany). The Rab7-eYFP
plasmid was previously constructed by Dr. M. Lakadamyali [34].
TheGFP-tagged dominant-negative Eps15 mutant E95/295andits
empty vector D3D2 were kindly provided by Dr. A. Benmerah and
Dr. A. Dautry-Varsat (Institute Pasteur, Paris, France). The
plasmids encoding GFP-tagged dominant-negative Rab5 mutant
Rab5S34N, wild-type Rab5-GFP, myc-tagged dominant-negative
Rab7 mutant Rab7T22N, and wild-type Rab7-myc were gifts from
Dr. P. van der Sluijs (University Medical Center, Utrecht, The
Netherlands). Cells were transfected with the plasmids using the
transfection reagent FuGENE, according to the manufacturer’s
protocol (Roche, Nutley, NJ, USA).
Viral Infectivity
To analyze the route of DENV cell entry, viral infectivity was
measured in HeLa cells expressing dominant-negative Eps15
mutants. At 30 hours post-transfection, cells were infected at MOI
5. At 21 hours post-infection, cells were washed with PBS,
trypsinized, fixed with 4% paraformaldehyde, and permeabilized
with 0.5% saponin in PBS containing 2% FBS. Expression of the
myc-tagged plasmids was detected with monoclonal antibody A-14
(Santa Cruz Biotechnology, Santa Cruz, CA, USA). DENV
infection was measured using the monoclonal antibody MAB8702
directed against the viral E protein (Chemicon, Hampshire,
United Kingdom). Cells were analyzed on a FACS Calibur
cytometer. The effect of chlorpromazine on DENV infectivity was
determined by an infectious center assay in BS-C-1 cells as
described before [25]. Chlorpromazine (15 mM) was added to the
cells 30 min prior to addition of the virus. At 1 hour post-
infection, cells were washed and fresh medium containing 20 mM
ammonium chloride was added. At 24 hours post-infection, cells
were fixed and stained intracellularly with MAB8702 to measure
infection [26].
Preparation of DiD-Labeled Virus
DENV serotype 2 strain PR159 S1, generously provided by Dr.
Richard Kuhn (Purdue University, Lafayette, IN, USA), was
produced and labeled with DiD as described previously [26].
Briefly, monolayers of C6/36 cells were inoculated with DENV at
MOI 0.1. At 72 hours post-infection, the progeny virions were
harvested, purified by ultracentrifugation, and cleared from
tartrate using 100 kD filter devices (Millipore, Amsterdam, The
Netherlands). Subsequently, 2 nmol DiD (Molecular Probes,
Eugene, OR, USA) dissolved in dimethyl sulfoxide (DMSO) was
mixed with approximately 5610
9 genome-containing DENV
particles while vortexing in a total DMSO concentration of less
than 2.5%. After 10 min, the unincorporated dye was removed by
gel filtration. DiD-labeled virus was stored at 4uC and used within
2 days. Virus preparations were analyzed with respect to the
infectious titer and the number of physical particles, as described
previously [26].
Live-Cell Imaging
Tracking experiments were carried out 24 to 48 hours post-
transfection as described previously [34]. Briefly, fluorescent
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(Melles-Griot, Carlsbad, CA, USA), YFP with a 532 nm Nd:YAG
laser (Crystalaser, Reno, NV, USA), and DiD with a 633 nm
helium-neon laser (Melles-Griot). For the clathrin experiments,
simultaneous images were recorded of DiD-labeled virions and
LCa-eYFP at 2 frames per second. In case of the Rab5/Rab7
experiments, the excitation of DiD was continuous, whereas the
excitation of CFP and YFP were alternated at 0.5 Hz. The
fluorescent emission was spectrally separated by 650 nm long-pass
dichroic mirrors (Chroma, Rockingham, VT, USA) and imaged
onto two separate areas of charge-coupled device camera (Cool-
SNAP HQ, Roper Scientific). A 665 nm long-pass filter was used
for the emission of DiD. For the emission of CFP and YFP,
bandpass filters of 480/40 nm and 585/35 nm were used,
respectively. The CFP and YFP filters were toggled by a motorized
wheel at 0.5 Hz synchronically with the 454 nm and 532 nm
lasers. Image analysis and single-particle tracking was performed
using custom-written IDL software as described previously
[26,49]. Briefly, background and noise were reduced by
convolution with a Gaussian spatial filter. Viral trajectories were
generated by pairing virus spots in each frame according to
proximity and similarity in intensity. Colocalization of viruses with
fluorescent cellular markers was identified with an automated
program and confirmed by eye, the criteria for colocalization
being that the objects move together and have at least partial
overlap. Only those particles that moved roughly within the focal
plane and showed more than a fivefold increase in fluorescence
intensity after membrane fusion were used for image analysis.
Characterization of the movement of DENV particles on the cell
surface was done by generating MSD-plots. The MSD at time
interval t is the average of all squared displacements throughout
the virus trajectory prior to or during association with clathrin.
The diffusion constants were calculated from the slope of the
MSD-plot.
Supporting Information
Figure S1 Effect of functional repression of Rab5 or Rab7 on
the infectivity of DENV S1 strain and NGC strain. DENV S1
(light gray bars) and NGC infectivity (black bars) in HeLa cells
expressing either wild-type Rab5 and Rab7 or dominant-negative
Rab5 (Rab5S34N) and Rab7 (Rab7T22N). At 30 hours post-
transfection, HeLa cells were infected with DENV for 21 hours
and subsequently stained for E protein-expression. Cells were
analyzed by flow cytometry, and the results are expressed as the
percentage infectivity in transfected cells. The experiment was
performed in triplicate, and the bars represent the average6SD.
Found at: doi:10.1371/journal.ppat.1000244.s001 (0.39 MB TIF)
Video S1 Surface motion of a DENV particle before capture by
a clathrin-coated pit. DENV particle (red, surrounded by a white
circle) that moves along the cell surface until it associates with
clathrin (green). Upon binding, the clathrin intensity increases
around the virus particle, indicating the maturation of the clathrin-
coated pit. Subsequently, the clathrin coat disappears and the
particle exhibits a rapid movement towards the perinuclear region
of the cell. Snapshots of this video are shown in Figure 2A. The
playback speed is 156real-time.
Found at: doi:10.1371/journal.ppat.1000244.s002 (8.35 MB AVI)
Video S2 Endocytic trafficking of DENV. Upon cell entry, the
DENV particle (red, surrounded by a white circle) moves rapidly
towards an intermediate endosome enriched in Rab5 (blue) and
Rab7 (green). This moment is clarified by the appearance of ‘‘(A)’’,
the arrow points at the intermediate endosome. Subsequently, the
intermediate endosome carrying the virus particle moves around
and merges with other endosomes (indicated by the arrows): a
Rab5-positive endosome (B) and an intermediate endosome (C).
Next, the intermediate endosome carrying the virus matures into a
late endosome through a gradual disappearance of Rab5 (D).
Membrane fusion occurs from within the Rab7-positive endosome
(E). Snapshots of this video are shown in Figure 3B. During real-
time imaging, DiD-labeled DENV particles were recorded at
2 Hz, whereas the excitation of Rab5-eCFP and Rab7-eYFP were
alternated at 0.5 Hz. Due to this recording scheme, the CFP and
YFP frames are updated every 4 frames in the video, whereas the
DiD signal is updated every frame, which might give the
impression that the endosomal markers are lagging behind the
virus particle. The hallmarks of colocalization are that the DiD
spot and the Rab signal at least show partial overlap when they are
simultaneously excited, and that both signals are linked and move
together in time. The playback speed is 106real-time.
Found at: doi:10.1371/journal.ppat.1000244.s003 (9.66 MB AVI)
Video S3 Endocytic trafficking of DENV. DENV particle (red,
surrounded by a white circle) that rapidly moves to a Rab5-positive
early endosome (blue) on time point (A). The early endosome
carrying the DENV particle acquires Rab7 (green) by merging with
an intermediate Rab5- and Rab7-positive endosome (B). Subse-
quently, the endosome gradually accumulates more Rab7 (C) and
gradually loses Rab5 (D). After merging of another large late
endosome (E), the virus finally fuses from within the Rab7-positive
late endosome(F).Real-timetrackingwasperformedasdescribed in
the legend of Video S2. The playback speed is 106real-time.
Found at: doi:10.1371/journal.ppat.1000244.s004 (10.20 MB
AVI)
Video S4 Some early endosomes gradually accumulate Rab7
molecules. Endosome enclosing a DENV particle (red, surrounded
by a white circle) that shows a gradual increase in the Rab7 signal
(green). Although during real-time imaging DiD-labeled particles
were excited at 2 Hz and Rab7-eYFP at 0.5 Hz, this video is
composed of only those frames in which DiD and YFP were
excited simultaneously. During the whole video, the virus particle
colocalizes with Rab5, but for clarity the signal is not depicted.
Snapshots of the maturation event are shown in Figure 3C. The
playback speed is 106real-time.
Found at: doi:10.1371/journal.ppat.1000244.s005 (8.00 MB AVI)
Video S5 Some early endosomes accumulate Rab7 by joining a
pre-existing Rab7-positive endosome. Endosome enclosing a
DENV particle (red, surrounded by a white circle) that merges
with a Rab7-positive endosome (green). The arrow indicates the
moment of the merging. Real-time imaging and the preparation of
the video are described in the legends of Videos S2 and S4,
respectively. During the whole video, the virus particle colocalizes
with Rab5, but for clarity the signal is not shown. Snapshots of the
maturation event are shown in Figure 3C. The playback speed is
106real-time.
Found at: doi:10.1371/journal.ppat.1000244.s006 (4.43 MB AVI)
Video S6 Some endosomes complete the maturation process by
a gradual release of Rab5 molecules. Endosome enclosing a
DENV particle (red, surrounded by a white circle) that shows a
gradual release of the Rab5 signal (blue). Real-time imaging was
performed as described in the legend to Video S2, but only those
frames in which DiD and CFP were excited simultaneously were
used in the video. Furthermore, the virus particle colocalizes with
Rab7 throughout the time trace, but for clarity the signal is not
depicted. Snapshots of the maturation event are shown in
Figure 3D. The playback speed is 106real-time.
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Video S7 Some endosomes complete the maturation process by
splitting off a Rab5-positive endosome. Endosome enclosing a
DENV particle (red, surrounded by a white circle) that splits off
and leaves the Rab5-positive endosome (blue). The moment of
splitting is indicated by the arrow, which points at the Rab5
endosome that is left behind. Real-time imaging and the
preparation of the video are described in the legends to Videos
S2 and S6, respectively. During the time trace, the virus particle
colocalizes with Rab7, but for clarity the signal is not depicted.
Snapshots of the maturation event are shown in Figure 3D. The
playback speed is 106real-time.
Found at: doi:10.1371/journal.ppat.1000244.s008 (2.93 MB AVI)
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